Are you Dr. Nicodemus?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Unither
15walnut St, Ste300
Wellesley, MA 02481Phone+1 781-416-1506
Summary
- Dr. Christopher Nicodemus, MD is a board certified internist in Wellesley, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Brigham and Women's HospitalFellowship, Allergy and Immunology, 1988 - 1990
- Brigham and Women's HospitalFellowship, Rheumatology, 1987 - 1988
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1984 - 1987
- SUNY Upstate Medical UniversityClass of 1984
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer Start of enrollment: 2012 Jun 15
- The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer Start of enrollment: 2017 May 30
Publications & Presentations
PubMed
- 60 citationsCA125- and tumor-specific T-cell responses correlate with prolonged survival in oregovomab-treated recurrent ovarian cancer patientsAlan N. Gordon, Birgit Schultes, B. Holly Gallion, Robert Edwards, Theresa L. Whiteside
Gynecologic Oncology. 2004-08-01 - 123 citationsRandomized, Placebo-Controlled Study of Oregovomab for Consolidation of Clinical Remission in Patients With Advanced Ovarian CancerJonathan S. Berek, Peyton T. Taylor, Alan N. Gordon, Mary J. Cunningham, Neil J. Finkler
Journal of Clinical Oncology. 2004-09-01 - 42 citationsImmune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancerVolker Möbus, Richard P. Baum, Marcus Bolle, Rolf Kreienberg, Antoine A. Noujaim
American Journal of Obstetrics and Gynecology. 2003-07-01